ID
41731
Descripción
Study ID: 111582 Clinical Study ID: 111582 Study Title: An Open Label Study to Examine the Effects of Low-fat and High-fat Meals on the Pharmacokinetics of Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00821054 https://clinicaltrials.gov/ct2/show/NCT00821054 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Lapatinib Trade Name: N/A Study Indication: Neoplasms, Breast The study consists of a screening, four study visits at day-1, week 1, 2 and 3 and a follow-up visit. This document documents any repeating Pharmacokinetics Blood measurements.
Link
https://clinicaltrials.gov/ct2/show/NCT00821054
Palabras clave
Versiones (1)
- 9/1/21 9/1/21 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
9 de enero de 2021
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Effects of Low-fat and high-fat meals on the Pharmacokinetics of Lapatinib in ErB2+ Breast Cancer patients, NCT00821054
Pharmacokinetics Repeat
- StudyEvent: ODM
Similar models
Pharmacokinetics Repeat
- StudyEvent: ODM
C0005767 (UMLS CUI-2)
C0205341 (UMLS CUI-3)
C2348184 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C1264639 (UMLS CUI [1,2])